Published in Am J Epidemiol on October 15, 1999
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A (2006) 3.89
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Norovirus and foodborne disease, United States, 1991-2000. Emerg Infect Dis (2005) 2.57
Gegenees: fragmented alignment of multiple genomes for determining phylogenomic distances and genetic signatures unique for specified target groups. PLoS One (2012) 2.25
Escherichia coli O157:H7: animal reservoir and sources of human infection. Foodborne Pathog Dis (2010) 2.12
Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun (2009) 2.07
Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect Immun (2006) 1.72
Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol (2011) 1.42
A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol (2010) 1.29
Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infect Dis (2009) 1.25
Acid resistance systems required for survival of Escherichia coli O157:H7 in the bovine gastrointestinal tract and in apple cider are different. Appl Environ Microbiol (2004) 1.24
Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun (2003) 1.23
Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol (2014) 1.22
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun (2008) 1.20
Detection, isolation, and molecular subtyping of Escherichia coli O157:H7 and Campylobacter jejuni associated with a large waterborne outbreak. J Clin Microbiol (2003) 1.20
Should health organizations use web 2.0 media in times of an infectious disease crisis? An in-depth qualitative study of citizens' information behavior during an EHEC outbreak. J Med Internet Res (2012) 1.13
Global transcriptional response of Escherichia coli O157:H7 to growth transitions in glucose minimal medium. BMC Microbiol (2007) 1.11
Genome-wide transposon mutagenesis reveals a role for pO157 genes in biofilm development in Escherichia coli O157:H7 EDL933. Infect Immun (2010) 1.10
Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol (2008) 1.09
Genetic differentiation of Escherichia coli O157:H7 clades associated with human disease by real-time PCR. J Clin Microbiol (2008) 1.08
A PDMS/paper/glass hybrid microfluidic biochip integrated with aptamer-functionalized graphene oxide nano-biosensors for one-step multiplexed pathogen detection. Lab Chip (2013) 1.07
Trace-back and trace-forward tools developed ad hoc and used during the STEC O104:H4 outbreak 2011 in Germany and generic concepts for future outbreak situations. Foodborne Pathog Dis (2012) 1.05
Determination of adhesin gene sequences in, and biofilm formation by, O157 and non-O157 Shiga toxin-producing Escherichia coli strains isolated from different sources. Appl Environ Microbiol (2011) 1.04
Large outbreak of verocytotoxin-producing Escherichia coli O157 infection in visitors to a petting farm in South East England, 2009. Epidemiol Infect (2011) 1.02
Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb Pathog (2011) 1.02
An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with consumption of fermented sausage; aspects of sausage production that increase the risk of contamination. Epidemiol Infect (2007) 1.01
Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7. Microbiology (2009) 1.01
Outbreaks of virulent diarrheagenic Escherichia coli--are we in control? BMC Med (2012) 1.01
O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respective role of cattle and humans. Vet Res (2012) 1.00
Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl Environ Microbiol (2008) 1.00
Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis (2011) 0.99
Enterohemorrhagic Escherichia coli exploits EspA filaments for attachment to salad leaves. Appl Environ Microbiol (2008) 0.97
Transcriptional responses of Escherichia coli K-12 and O157:H7 associated with lettuce leaves. Appl Environ Microbiol (2012) 0.97
A Gapless, Unambiguous Genome Sequence of the Enterohemorrhagic Escherichia coli O157:H7 Strain EDL933. Genome Announc (2014) 0.97
A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in China. PLoS One (2012) 0.97
Rapid and specific detection of escherichia coli serogroups O26, O45, O103, O111, O121, O145, and O157 in ground beef, beef trim, and produce by loop-mediated isothermal amplification. Appl Environ Microbiol (2012) 0.96
Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl Environ Microbiol (2007) 0.96
Physiological and molecular responses of Lactuca sativa to colonization by Salmonella enterica serovar Dublin. Appl Environ Microbiol (2007) 0.96
Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun (2008) 0.94
The arable ecosystem as battleground for emergence of new human pathogens. Front Microbiol (2014) 0.94
Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun (2010) 0.93
Inactivation of alternative sigma factor 54 (RpoN) leads to increased acid resistance, and alters locus of enterocyte effacement (LEE) expression in Escherichia coli O157 : H7. Microbiology (2009) 0.92
Shiga toxin-producing Escherichia coli in yaks (Bos grunniens) from the Qinghai-Tibetan Plateau, China. PLoS One (2013) 0.91
Surface structures involved in plant stomata and leaf colonization by shiga-toxigenic Escherichia coli o157:h7. Front Microbiol (2011) 0.90
Alfalfa seed decontamination in a Salmonella outbreak. Emerg Infect Dis (2003) 0.89
Development of an immunomagnetic bead-immunoliposome fluorescence assay for rapid detection of Escherichia coli O157:H7 in aqueous samples and comparison of the assay with a standard microbiological method. Appl Environ Microbiol (2005) 0.89
Escherichia coli pathotypes occupy distinct niches in the mouse intestine. Infect Immun (2014) 0.89
Comparison of methods of extracting Salmonella enterica serovar Enteritidis DNA from environmental substrates and quantification of organisms by using a general internal procedural control. Appl Environ Microbiol (2006) 0.89
Association between indicators of cattle density and incidence of paediatric haemolytic-uraemic syndrome (HUS) in children under 15 years of age in France between 1996 and 2001: an ecological study. Epidemiol Infect (2005) 0.87
Pathogen detection, testing, and control in fresh broccoli sprouts. Nutr J (2006) 0.86
Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coli. Curr Infect Dis Rep (2013) 0.86
Type 1 fimbriation and its phase switching in diarrheagenic Escherichia coli strains. Clin Diagn Lab Immunol (2001) 0.86
Gene expression induced in Escherichia coli O157:H7 upon exposure to model apple juice. Appl Environ Microbiol (2009) 0.86
Functional analysis of ycfR and ycfQ in Escherichia coli O157:H7 linked to outbreaks of illness associated with fresh produce. Appl Environ Microbiol (2011) 0.85
Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model. Infect Immun (2015) 0.84
Outbreak of Escherichia coli 0157:H7 related to animal contact at a petting zoo. Can J Infect Dis (2002) 0.84
Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS One (2013) 0.84
Internalization of Escherichia coli o157:h7 by bovine rectal epithelial cells. Front Microbiol (2011) 0.84
Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli. J Clin Microbiol (2004) 0.84
Use of the duplex TaqMan PCR system for detection of Shiga-like toxin-producing Escherichia coli O157. J Clin Microbiol (2005) 0.84
High stability of Stx2 phage in food and under food-processing conditions. Appl Environ Microbiol (2011) 0.82
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Front Cell Infect Microbiol (2012) 0.82
Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin. Infect Immun (2014) 0.82
Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. Clin Vaccine Immunol (2012) 0.81
Public health in crisis: outbreaks of Escherichia coli O157:H7 infections in Japan. Am J Epidemiol (1999) 0.81
Contribution of urease to colonization by Shiga toxin-producing Escherichia coli. Infect Immun (2012) 0.81
Influence of plasmid pO157 on Escherichia coli O157:H7 Sakai biofilm formation. Appl Environ Microbiol (2009) 0.81
Escherichia coli common pilus (ECP) targets arabinosyl residues in plant cell walls to mediate adhesion to fresh produce plants. J Biol Chem (2014) 0.80
Comparison of a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to pulsed-field gel electrophoresis to determine the effect of repeated subculture and prolonged storage on RFLP patterns of Shiga toxin-producing Escherichia coli O157:H7. J Clin Microbiol (2006) 0.80
Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157:H7: an in silico approach. Adv Appl Bioinform Chem (2015) 0.79
An outbreak of Escherichia coli O157 gastroenteritis in a care home for the elderly. Epidemiol Infect (2006) 0.79
Functional and phylogenetic analysis of ureD in Shiga toxin-producing Escherichia coli. J Bacteriol (2010) 0.79
Detection of shiga toxins by lateral flow assay. Toxins (Basel) (2015) 0.78
Toxicity of Shiga toxin 1 in the central nervous system of rabbits. Infect Immun (2001) 0.78
Epidemiological study of E. coli O157:H7 isolated in Northern Ireland using pulsed-field gel electrophoresis (PFGE). Ulster Med J (2008) 0.77
Bovine colostral antibody against verotoxin 2 derived from Escherichia coli O157:H7: resistance to proteases and effects in beagle dogs. Comp Med (2009) 0.77
Persistence of Pathogenic and Non-Pathogenic Escherichia coli Strains in Various Tropical Agricultural Soils of India. PLoS One (2015) 0.77
Predicting statistical properties of open reading frames in bacterial genomes. PLoS One (2012) 0.76
Evaluation of aerated steam treatment of alfalfa and mung bean seeds to eliminate high levels of Escherichia coli O157:H7 and O178:H12, Salmonella enterica, and Listeria monocytogenes. Appl Environ Microbiol (2013) 0.76
Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes. PLoS One (2015) 0.76
Phenotypic and Genotypic Characteristics of Shiga Toxin-Producing Escherichia coli Isolated from Surface Waters and Sediments in a Canadian Urban-Agricultural Landscape. Front Cell Infect Microbiol (2016) 0.75
Differences in internalization and growth of Escherichia coli O157:H7 within the apoplast of edible plants, spinach and lettuce, compared with the model species Nicotiana benthamiana. Microb Biotechnol (2017) 0.75
An improved enrichment broth for isolation of Escherichia coli O157, with specific reference to starved cells, from radish sprouts. Appl Environ Microbiol (2003) 0.75
Biofilm-Forming Abilities of Shiga Toxin-Producing Escherichia coli Isolates Associated with Human Infections. Appl Environ Microbiol (2015) 0.75
Fiber-Optic Fluoroimmunoassay System with a Flow-Through Cell for Rapid On-Site Determination of Escherichia coli O157:H7 by Monitoring Fluorescence Dynamics. Biosensors (Basel) (2013) 0.75
Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice. BMC Genomics (2015) 0.75
In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. Microb Genom (2016) 0.75
Study of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11. In Silico Pharmacol (2017) 0.75
Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012. Emerg Infect Dis (2016) 0.75
Phytic Acid and Sodium Chloride Show Marked Synergistic Bactericidal Effects against Nonadapted and Acid-Adapted Escherichia coli O157:H7 Strains. Appl Environ Microbiol (2015) 0.75
Contribution of cropland to the spread of Shiga toxin phages and the emergence of new Shiga toxin-producing strains. Sci Rep (2017) 0.75
[Globosides as key players in the pathophysiology of Shiga toxin-associated acute kidney failure and Fabry disease]. Pathologe (2014) 0.75
The EspF N-Terminal of Enterohemorrhagic Escherichia coli O157:H7 EDL933w Imparts Stronger Toxicity Effects on HT-29 Cells than the C-Terminal. Front Cell Infect Microbiol (2017) 0.75
Construction and Experimental Validation of a Quantitative Kinetic Model of Nitric Oxide Stress in Enterohemorrhagic Escherichia coli O157:H7. Bioengineering (Basel) (2016) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
Pyrido(2,3-d)pyrimidine antibacterial agents. 3. 8-Alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids and their derivatives. J Med Chem (1975) 8.52
Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology (1990) 6.34
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin. Antimicrob Agents Chemother (1979) 4.49
Molecular diversity of the NMDA receptor channel. Nature (1992) 3.76
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation (1992) 3.73
Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 3.59
Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother (1980) 3.48
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood (1999) 3.46
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother (2000) 3.03
Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene (1989) 3.00
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother (1999) 2.88
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer (2010) 2.82
Polypeptide chain elongation factor 1 alpha (EF-1 alpha) from yeast: nucleotide sequence of one of the two genes for EF-1 alpha from Saccharomyces cerevisiae. EMBO J (1984) 2.77
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J Virol (1998) 2.62
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol Cell Biol (1993) 2.48
In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett (1997) 2.40
Purification and properties of a cephalosporinase from Enterobacter cloacae. Antimicrob Agents Chemother (1980) 2.37
Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet (1999) 2.32
Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis (2001) 2.30
Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice. Cell (1995) 2.25
Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest (1995) 2.20
Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes. EMBO J (1997) 2.19
Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature (1992) 2.18
A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol (2000) 2.16
Studies on the nucleotide sequence of pseudouridine-containing 5S RNA from Saccharomyces cerevisiae. J Biochem (1974) 2.15
Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem (2001) 2.14
rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced membrane ruffling in KB cells. Mol Cell Biol (1994) 2.12
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest (1999) 2.09
Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet (1986) 2.00
NMR scalar couplings across Watson-Crick base pair hydrogen bonds in DNA observed by transverse relaxation-optimized spectroscopy. Proc Natl Acad Sci U S A (1998) 1.99
Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer (2006) 1.91
Purification and properties of cephalosporinase in Escherichia coli. Antimicrob Agents Chemother (1980) 1.90
An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J (1997) 1.90
Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J (1992) 1.87
cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci (2000) 1.86
Kawasaki disease in families. Pediatrics (1989) 1.83
Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci U S A (1988) 1.82
Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood (1999) 1.77
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol (2000) 1.73
Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole. Anesthesiology (1998) 1.73
Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res (1994) 1.73
Decreased tensile strength of an epidural catheter during its removal by grasping with a hemostat. Anesth Analg (2001) 1.72
Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord (1995) 1.70
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia (1997) 1.66
Genetic diversity of hantaviruses isolated in china and characterization of novel hantaviruses isolated from Niviventer confucianus and Rattus rattus. Virology (2000) 1.64
Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62
Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62
A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun (2000) 1.62
Deoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett (1996) 1.61
Insertion of a carbapenemase gene cassette into an integron of a Pseudomonas aeruginosa plasmid. J Antimicrob Chemother (1996) 1.61
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Chymase-dependent angiotensin II formation in human vascular tissue. Circulation (1999) 1.60
Template-directed polymerization of oligoadenylates using cyanogen bromide. Biochemistry (1986) 1.60
Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation (1993) 1.59
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol (1999) 1.59
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int (2000) 1.59
Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol (1998) 1.58
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol (2001) 1.57
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation (1998) 1.57
Clinical analysis of a series of vertebral aneurysm cases. Neurosurgery (1992) 1.57
A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol (1988) 1.56
An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J Biochem (1993) 1.55
Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol (1995) 1.54
Pax1 and Pax9 synergistically regulate vertebral column development. Development (1999) 1.53
Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr (2002) 1.53
Role of permeability in the activities of beta-lactams against gram-negative bacteria which produce a group 3 beta-lactamase. Antimicrob Agents Chemother (1999) 1.52
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group. Lancet (2000) 1.51
Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging. Radiology (1987) 1.50
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
Synthesis of deoxyoligonucleotides containing 7-deazaadenine: recognition and cleavage by restriction endonuclease Bgl II and Sau 3AI (nucleosides and nucleotides Part 55). Nucleic Acids Res (1984) 1.50
Both primary motor cortex and supplementary motor area play an important role in complex finger movement. Brain (1993) 1.49
Late onset diabetes mellitus in patients with hereditary aceruloplasminemia. Intern Med (1996) 1.47
Mouse vaginal opening is an apoptosis-dependent process which can be prevented by the overexpression of Bcl2. Dev Biol (1997) 1.47
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. J Med Chem (1997) 1.45
Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol (1995) 1.45
Low prevalence of Helicobacter pylori in individuals with HTLV-I infection. Eur J Gastroenterol Hepatol (1999) 1.43
Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Colorectal Dis (2003) 1.43
Purification of an octamer sequence (ATGCAAAT)-binding protein from human B cells. Nucleic Acids Res (1987) 1.42
Neural substrates for conditioned taste aversion in the rat. Behav Brain Res (1994) 1.41
Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening. Endoscopy (2012) 1.41
Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gan (1984) 1.40
Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro. Biochem Biophys Res Commun (2000) 1.40